New hope in the horizon: Cancer stems cells

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 4, 2010, Pages 237-242

  Bhattacharyya, Shalmoli ^a   Khanduja, Kishan Lal ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cancer; Stem cells; Therapy

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL PROLIFERATION; CYTOLOGY; DISEASE FREE SURVIVAL; HUMAN; METASTASIS; METHODOLOGY; MOUSE; MOUSE MUTANT; NEOPLASM; NONOBESE DIABETIC MOUSE; ONCOLOGY; PATHOLOGY; REVIEW; STEM CELL; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; HUMANS; MEDICAL ONCOLOGY; MICE; MICE, INBRED NOD; MICE, SCID; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOPLASTIC STEM CELLS; STEM CELLS; TREATMENT OUTCOME;

EID: 77950548814     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq013     Document Type: Review

References (59)

1. Dick JE. Stem cell concepts renew cancer research. Blood 2008, 112: 4793-4807.
2. Hanahan D and Weinberg RA. The hallmarks of cancer. Cell 2000, 100: 57-70.
3. Fearon ER and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61: 759-767.
4. Morrison SJ, Qian D, Jerebek L, Thiel BA, Park IK, Ford PS and Kiel MJ, et al. A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. J Immunol 2002, 168: 635-642.
5. Potten CS and Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990, 110: 1001-1020.
6. Reya T, Morrison SJ, Clarke MF and Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414: 105-111.
7. Kuehnle I and Goodell MA. The therapeutic potential of stem cells from adults. Br Med J 2002, 325: 372-376.
8. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100: 3983-3988. (Pubitemid 36418143)
9. Romano G. The role of adult stem cells in carcinogenesis. Drug News Perspect 2005, 18: 555-559.
10. Bapat SA. Evolution of cancer stem cells. Semin Cancer Biol 2007, 17: 204-213.
11. Kummermehr J and Trott KR. Tumor stem cells. In: Potten CS (ed.). Stem Cells. London: Academic Press, 1997, 363-399.
12. Heppner GH. Tumor heterogeneity. Cancer Res 1984, 44: 2259-2265.
13. Nowell PC. Mechanisms of tumor progression. Cancer Res 1986, 46: 2203-2207.
14. Hu Y, Swerdlow S, Duffy TM, Weinmann R, Lee FY and Li S. Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. Proc Natl Acad Sci USA 2006, 103: 16870-16875.
15. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL and Gotlib J, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004, 351: 657-667.
16. Minami Y, Stuart SA, Ikawa T, Jiang Y, Banno A, Hunton IC and Young DJ, et al. BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proc Natl Acad Sci USA 2008, 105: 17967-17972.
17. Rizvi AZ and Wong MH. Epithelial stem cells and their niche: there's no place like home. Stem Cells 2005, 23: 150-165.
18. Yen TH and Wright NA. The gastrointestinal tract stem cell niche. Stem Cell Rev 2006, 80: 203-212.
19. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T and Sherlock G, et al. The prognostic role of a gene signature from tumorigenic breastcancer cells. N Engl J Med 2007, 356: 217-226.
20. Li L and Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006, 66: 4553-4557.
21. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M and Fuchs E. Defining the epithelial stem cell niche in skin. Science 2004, 303: 359-363. (Pubitemid 38095773)
22. Scopelliti A, Cammareri P, Catalano V, Saladino V, Todaro M and Stassi G. Therapeutic implications of cancer initiating cells. Expert Opin Biol Ther 2009, 9: 1005-1016.
23. Shackleton M, Quintana E, Fearon ER and Morrison SJ. Heterogeneity in cancer: cancer stem cell versus clonal evolution. Cell 2009, 138: 822-829.
24. Oravecz-Wilson KI, Philips ST, Yilmaz ÖH, Ames HM, Li L, Crawford BD and Gauvin AM, et al. Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. Cancer cells 2009, 16: 137-148.
25. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB and Dewhirst MW, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444: 756-760.
26. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN and Qian D, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458: 780-783.
27. Carney DN, Gazdar AF, Bunn PA, Jr and Guccion JG. Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients. Stem Cells 1982, 1: 149-164.
28. Bonnet D and Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3: 730-737.
29. O'Brien CA, Pollett A, Gallinger S and Dick JE. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 2007, 445: 1061.
30. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschale C and De'Maria R. Identification and expansion of human colon cancerinitiating cells. Nature 2007, 445: 111-115.
31. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW and Hoey T, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007, 104: 10158-10163.
32. Gu G, Yuan J, Wills M and Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007, 67: 4807-4815.
33. Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65: 10946-10951.
34. Li HC, Stoicov C, Rogers AB and Houghton J. Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 2006, 12: 363-371.
35. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S and Van Belle PA, et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005, 65: 9328-9337.
36. Prince ME, Sivanandan R, Kaczorowski A, Clarke MF, Ailles LE, Wolf GT and Kaplan MJ, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007, 104: 973-978.
37. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S and Crowley D, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005, 121: 823-835.
38. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW and Gobel U. A distinct side population of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004, 101: 14228-142339.
39. Pearce DJ, Taussig D, Simpson C, Allen K, Rohatiner AZ and Lister TA. Characterisation of cells with high aldehyde dehydrogenase activity from cord blood and acute AML samples. Stem Cells 2006, 24: 975-985.
40. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V and Wicha M, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007, 67: 1030-1037.
41. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM and Morrison SJ. Efficient tumor formation by single human melanoma cells. Nature 2008, 456: 593-598.
42. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T and Henkelman RM, et al. Identification of human brain tumor initiating cells. Nature 2004, 432: 396-401.
43. Xin L, Lawson DA and Witte ON. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 2005, 102: 6942-6947.
44. Zang S, Balch C, Chan MW, Lai H, Matei D, Schilder JM and Yan PS, et al. Identification and characterization of ovarian cancer initiating cells from primary human tumors. Cancer Res 2008, 68: 4311-4320.
45. Jordan CT, Guzman ML and Noble M. Cancer stem cells. N Engl J Med 2006, 355: 1253-1261.
46. Pardal R, Clarke MF and Morrison SJ. Applying the principles of stemcell biology to cancer. Nat Rev Cancer 2003, 3: 895-902.
47. Molofsky AV, Pardal R and Morrison SJ. Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 2004, 16: 700-707.
48. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K and Hintz L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003, 423: 409-414.
49. Taipale J and Beachy PA. The Hedgehog and Wnt signalling pathways in cancer. Nature 2001, 411: 349-354.
50. Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM and Lagoo A, et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007, 12: 528-541.
51. Lessard J and Sauvagea G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003, 423: 255-260.
52. Molofsky AV, He S, Bydon M, Morrison SJ and Pardal R. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 2005, 19: 1432-1437.
53. Lowe SW and Sherr CJ. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 2003, 13: 77-83.
54. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM and Eberhart CG. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006, 66: 7445-7452.
55. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J and Kwon HY, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009, 458: 776-779.
56. Catalano A, Rodilossi S, Caprari P, Coppola V and Procopio A. 5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation. EMBO J 2005, 24: 170-179.
57. Wymann MP and Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008, 9: 162-176.
58. Chen Y, Hu Y, Zhang H, Peng C and Li S. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nature Genet 2009, 41: 783-792.
59. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA and Lander ES. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138: 645-659.